![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1348455
¼¼°èÀÇ ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2024-2030³â) - MedCoreNeedleless Connector Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Hospital NLCs and Non-Hospital NLCs |
2023³â ¼¼°èÀÇ ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå ±Ô¸ð´Â 13¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î º¸À̸ç Àü³â 12¾ï 6,000¸¸ ´Þ·¯¿¡¼ 5.8% Áõ°¡ÇÒ Àü¸ÁÀÔ´Ï´Ù. ÇâÈÄ ¿¹Ãø¿¡¼ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 4.5%·Î ±Ã±ØÀûÀ¸·Î 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ²ÙÁØÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¸ñÇÒ¸¸ÇÑ °ÍÀº Becton Dickinson(BD)°ú ICU MedicalÀÌ ÇöÀç ¼¼°èÀÇ ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.
´Ù°¡¿À´Â ¿¹Ãø ±â°£ µ¿¾È ½ÅÈï ½ÃÀåÀº ±â°è½Ä ¹ëºê ÀåÄ¡·ÎÀÇ Á¡ÁøÀûÀÎ ÀüȯÀÇ ÀÌÁ¡À» ´©¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â°è½Ä ÆÇ¸· ´Ïµé¸®½º Ä¿³ØÅÍ(NLC)ÀÇ Æ¯Á¤ ±¸¼ºÀº ¸î °¡Áö ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°Áö¸¸, »ó´ç¼öÀÇ ±â°è½Ä ÆÇ¸·Àº Àü¹ÝÀûÀΠȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â ±â´ÉÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ÀϹÝÀûÀ¸·Î ºÐÇÒ Áß°Ý Á¦Ç°¿¡ ºñÇØ °¡°ÝÀÌ ¾à°£ ³ôÁö¸¸, ±â°è½Ä ¹ëºê NLCÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È Àüü ½ÃÀå °¡Ä¡¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
2023³â, Becton Dickinson(BD)Àº ´Ïµé¸®½º Ä¿³ØÅÍ(NLC) ½ÃÀåÀÇ ¼¼°èÀÇ ¸®´õ·Î¼ÀÇ ÁöÀ§¸¦ ±»Çû½À´Ï´Ù. ÀÌ È¸»ç´Â ±¤¹üÀ§ÇÑ ÁÖÀÔ Ä¡·á ½ÃÀå¿¡¼ ¾ÐµµÀûÀÎ Á¸Àç°¨À» º¸¿©ÁÖ°í ÀÖÀ¸¸ç ºê·£µå ÀÎÁöµµ¿Í °æÀï·ÂÀÖ´Â °¡°ÝÀ¸·Î ´Ù¾çÇÑ ÀÏȸ¿ë Á¦Ç°À» ´ë·®À¸·Î Á¦Á¶ ¹× ÆÇ¸ÅÇÏ´Â ´É·ÂÀ» ¸ðµÎ °ÈÇϰí ÀÖ½À´Ï´Ù.
2023³â ´Ïµé¸®½º Ä¿³ØÅÍ ½ÃÀå¿¡¼ 2À§ ÀÚ¸®¸¦ È®º¸ÇÑ °ÍÀº ICU MedicalÀÔ´Ï´Ù. ICU MedicalÀº ±â°è½Ä ¹ëºê Ä¿³ØÅÍ ºÐ¾ß¿¡¼ Clave(TM) Ä¿³ØÅ͸¦ Á¦°øÇÕ´Ï´Ù. Clave(TM) Ä¿³ØÅÍÀÇ Çõ½ÅÀûÀÎ µðÀÚÀÎÀº ¿ÜºÎ ºê·£Æ® ij´¼¶ó¸¦ ºÐÇÒ °Ý¸· ±¸Á¶¿¡ ¿øÈ°ÇÏ°Ô ÅëÇÕÇÏ¿© ¸ðµç Ç¥ÁØ ¼öÇü ·ç¾î Ä¿³ØÅÍ¿ÍÀÇ È£È¯¼ºÀ» º¸ÀåÇÕ´Ï´Ù.
´Ïµé¸®½º Ä¿³ØÅÍ´Â ´Ù¸¥ ´Ù¾çÇÑ ÀÏȸ¿ë ÀÇ·á Á¦Ç°°ú ¸¶Âù°¡Áö·Î ºñ±³Àû Àú·ÅÇÑ ºñ¿ëÀ¸·Î »ý»ê ¹× ÆÇ¸ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãø¸éÀº ´ë±â¾÷¿¡ ºñÇØ ´õ °£´ÜÇÏ°í ºñ¿ë È¿À²ÀûÀÎ Á¦Ç°À» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÏ´Â ¼Ò±Ô¸ð ȸ»ç°¡ ½ÃÀå¿¡ ÁøÀÔÇÏ´Â Àμ¾Æ¼ºê·Î ÀÛ¿ëÇÕ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ¿¹Ãø ±â°£ µ¿¾ÈÀÌ ½ÃÀå¿¡¼ Áö¹èÀûÀÎ Ç÷¹À̾î´Â NLC Á¦Ç°À» ´Ù¸¥ ÁÖÀÔ ¿ä¹ý ÀåÄ¡¿Í ¹øµé·Î Á¦°ø ÇÒ ¼öÀÖ´Â Ç÷¹À̾ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ´Ïµé¸®½º Ä¿³ØÅÍ(Needleless Connector) ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä/ºÎ¹®º°¡¤Áö¿ªº° µ¿Çâ/°æÀï ±¸µµ µî Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
In 2023, the worldwide needleless connector market exhibited a total worth of $1.33 billion, reflecting a 5.8% surge compared to the previous year's $1.26 billion. Projections for the upcoming period indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 4.5%, ultimately reaching $1.80 billion. Notably, Becton Dickinson (BD) and ICU Medical are currently the dominant players in the global needleless connector market.
Our comprehensive medical market research involved an extensive analysis of more than 15 intravenous set companies spanning seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts. The full report suite on the global intravenous sets market encompasses both hospital NLCs and non-hospital NLCs.
In the upcoming forecast period, emerging markets are set to reap the benefits of a gradual shift towards mechanical valve devices. Although certain configurations of mechanical valve needleless connectors (NLCs) raise some concerns, a significant number of them have proven their capability to enhance overall patient outcomes. Even though these devices typically come with a slightly higher price tag compared to split septum products, the increasing adoption of mechanical valve NLCs is expected to yield a favorable impact on the overall market's value in the years to come.
In 2023, Becton Dickinson (BD) solidified its position as the global leader in the Needleless Connector (NLC) market. Notably, Becton Dickinson also functions as an infusion pump manufacturer, leveraging this capability to bundle NLCs with its devices. The company maintains a commanding presence in the broader infusion therapy market, bolstering both its brand recognition and the ability to manufacture and market various disposable products in significant quantities at competitive prices.
Securing the second position in the global NLC market in 2023 was ICU Medical. In the realm of mechanical valve connectors, ICU Medical offers the Clave™ connector. The Clave™ connector's innovative design seamlessly integrates the external blunt cannula into the split septum structure, ensuring compatibility with any standard male Luer connector.
Needleless connectors, much like various other disposable healthcare products, can be produced and sold at relatively low costs. This aspect serves as an incentive for smaller companies to enter the market, aiming to provide simpler and more cost-effective products compared to their larger counterparts. Nonetheless, throughout the forecast period, the dominant players in this market are expected to be those capable of bundling NLC products with other infusion therapy devices.